Dual antiplatelet platelet therapy duration following coronary stenting (original) (raw)
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial
Matteo Tebaldi, C. Tumscitz, Marco Borghesi, Marco Valgimigli
Circulation, 2012
View PDFchevron_right
Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?
Angeliki Papapanagiotou
European heart journal, 2015
View PDFchevron_right
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting St...
Julinda Mehilli
American Heart Journal, 2009
View PDFchevron_right
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study
Javad Kojuri
Medicine, 2016
View PDFchevron_right
Causes of late mortality with dual antiplatelet therapy after coronary stents
Dean Kereiakes
European heart journal, 2015
View PDFchevron_right
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and America...
Peter Lockhart
Catheterization and Cardiovascular Interventions, 2007
View PDFchevron_right
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary LesionsResults From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduce...
Soo-jin Kang
Journal of the American College of Cardiology, 2011
View PDFchevron_right
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Sangsu Park
Circulation, 2012
View PDFchevron_right
Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
LONG ZENG
Anatolian journal of cardiology, 2016
View PDFchevron_right
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials
Giuseppe Ferrante
Circulation. Cardiovascular interventions, 2017
View PDFchevron_right
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Dean Kereiakes
The New England journal of medicine, 2014
View PDFchevron_right
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
Francesco Costa, Sara Ariotti
European Heart Journal, 2015
View PDFchevron_right
Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy
Corrado Lettieri
The American Journal of Cardiology, 2008
View PDFchevron_right
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)
Won-Jang Kim
American Heart Journal, 2010
View PDFchevron_right
Triple Versus Dual Antiplatelet Therapy After Coronary Stenting
Bong-Ki Lee
Journal of The American College of Cardiology, 2005
View PDFchevron_right
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ioannis Mastoris, samantha sartori
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
seyed fazel Hosseini
The Journal of Tehran University Heart Center, 2012
View PDFchevron_right
Comparison of Triple Versus Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation (from the DECLARE–Long Trial)
Duk Jae park
American Journal of Cardiology, 2007
View PDFchevron_right
Individualization of dual antiplatelet therapy duration after drug-eluting stent implantation: paradigm and reality
Adnan Kastrati
European Heart Journal, 2013
View PDFchevron_right
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial
Hélio Castello
JAMA, 2013
View PDFchevron_right
Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting
Lien Quach
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016
View PDFchevron_right
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Ioannis Mastoris, Gennaro Giustino
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: A meta-analysis of randomized trials
Giuseppe Ferrante
International Journal of Cardiology, 2013
View PDFchevron_right
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyper...
Matteo Tebaldi, C. Tumscitz, Marco Borghesi, Fabrizio Ferrari, A. Scalone, Marco Valgimigli, Andrea Zuffi
2010
View PDFchevron_right
Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Philippe Généreux
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial
Pil Lee
The American journal of cardiology, 2017
View PDFchevron_right
Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents
Giulia Renda
Drugs, 2005
View PDFchevron_right
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Francesco Costa
BMJ (Clinical research ed.), 2015
View PDFchevron_right
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study
Dean Kereiakes
JAMA cardiology, 2017
View PDFchevron_right